Indoleamine 2,3-dioxygenase (IDO) as the enzyme of Tryptophan, reduced IDO activity and expression in sputum of COPD patients is negatively correlated with clinical severity (Naz et al., 2019). The gene discussed is IDO1; the disease is chronic obstructive pulmonary disease.